PDCD1 and neoplasm: One of the potential problems with CAR-T cells is their exhaustion in the case of solid tumors, which refers to loss of effector function and persistent inhibitory receptor expression due to chronic antigen exposure and the immunosuppressive tumor microenvironment and immune checkpoint programmed death -1 (PD-1) is closely linked with CAR-T cell exhaustion (21–24).